GPC3 and hepatocellular carcinoma: PIVKA-II, glypican-3 (GP3) and Squamous Cell Carcinoma Antigen -1 (SCCA-1) had been proposed as new HCC-biomarkers in a study including 19 patients with histologically proven NAFLD-related HCC and 31 patients with alcohol-related HCC [118].